Provided by Tiger Trade Technology Pte. Ltd.

Macrogenics

4.00
-0.1100-2.68%
Volume:181.05K
Turnover:729.46K
Market Cap:254.58M
PE:-17.46
High:4.12
Open:4.08
Low:3.96
Close:4.11
52wk High:5.08
52wk Low:1.29
Shares:63.65M
Float Shares:57.01M
Volume Ratio:0.61
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2291
EPS(LYR):-1.1815
ROE:-225.85%
ROA:-8.05%
PB:5.94
PE(LYR):-3.39

Loading ...

MacroGenics CEO Eric Risser to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Yesterday

MacroGenics Amends 8-K to Update Pro Forma Financials for CDMO Asset Sale to Bora Pharmaceuticals

Reuters
·
Sep 04

MacroGenics SVP, GC and Secretary Jeffrey Stuart Peters Disposes of 31,105 Common Shares for $129,086.75

Reuters
·
Aug 21

Macrogenics is Maintained at Buy by B. Riley Securities

Dow Jones
·
Aug 18

B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating

MT Newswires Live
·
Aug 17

MacroGenics (MGNX) Gets a Hold from Stifel Nicolaus

TIPRANKS
·
Aug 14

UPDATE: Macrogenics Q2 Adj. EPS $(0.27) Misses $(0.13) Estimate, Sales $32.832M Miss $67.456M Estimate

Benzinga Earnings
·
Aug 14

MacroGenics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Macrogenics Q2 EPS $(0.31) Misses $0.02 Estimate, Sales $32.832M Miss $67.456M Estimate

Benzinga Earnings
·
Aug 14

MacroGenics Posts Corporate Overview Highlighting Oncology Pipeline, Cash Runway Through 2028

Reuters
·
Aug 14

MacroGenics Q2 Revenue Misses Estimates, Posts Profit on Asset Sale

Reuters
·
Aug 14

MacroGenics Q2 Net Income USD 19.5 Million

Reuters
·
Aug 14

MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position

THOMSON REUTERS
·
Aug 14

MacroGenics Q2 EPS USD 0.31

THOMSON REUTERS
·
Aug 14

MacroGenics - Workforce to be Reduced to About 140 Employees by Year-End

THOMSON REUTERS
·
Aug 14

MacroGenics Rises on $10 Million Milestone Payment from Gilead

Reuters
·
Aug 12

MacroGenics Raih Pembayaran USD 10 Juta Usai Gilead Ambil Lisensi Program Bispesifik Praklinis

Reuters
·
Aug 12

MacroGenics - Remains Eligible to Receive up to Approximately $1.6 Bln in Additional Development

THOMSON REUTERS
·
Aug 12

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

THOMSON REUTERS
·
Aug 12

MacroGenics Inc Expected to Post a Loss of 13 Cents a Share - Earnings Preview

Reuters
·
Aug 10